These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An immunoperoxidase study of immunological factors in skin lesions across the spectrum of leprosy. Ridley MJ; Russell DF; Ridley DS Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):11-9. PubMed ID: 7042610 [TBL] [Abstract][Full Text] [Related]
9. Serodiagnosis of leishmaniasis. Kar K Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932 [TBL] [Abstract][Full Text] [Related]
10. Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study. Ridley MJ; Wells CW Am J Pathol; 1986 Apr; 123(1):79-85. PubMed ID: 3963151 [TBL] [Abstract][Full Text] [Related]
11. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. Mosser DM; Edelson PJ J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545 [TBL] [Abstract][Full Text] [Related]
12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. Titus RG; Lima GC; Engers HD; Louis JA J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088 [TBL] [Abstract][Full Text] [Related]
13. The role of the macrophage in cutaneous leishmaniasis. Farah FS; Samra SA; Nuwayri-Salti N Immunology; 1975 Oct; 29(4):755-64. PubMed ID: 1184120 [TBL] [Abstract][Full Text] [Related]
14. [Leishmaniasis: principles of the immune response and function of nitric oxide]. Bogdan C Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):409-14. PubMed ID: 9880934 [TBL] [Abstract][Full Text] [Related]
15. [Role of Langerhans cells in the immunity of leishmaniasis]. Zuluaga M; Robledo SM Biomedica; 2004 Sep; 24(3):302-17. PubMed ID: 15551883 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Castés M; Agnelli A; Rondón AJ Clin Exp Immunol; 1984 Aug; 57(2):279-86. PubMed ID: 6467674 [TBL] [Abstract][Full Text] [Related]
17. [Immunopathology of American tegumentary leishmaniasis]. Castés M; Tapia FJ Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916 [TBL] [Abstract][Full Text] [Related]
18. In situ characterization of the human host response to Leishmania panamensis. Palma GI; Saravia NG Am J Dermatopathol; 1997 Dec; 19(6):585-90. PubMed ID: 9415615 [TBL] [Abstract][Full Text] [Related]
19. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. Murray HW; Rubin BY; Carriero S; Acosta AM J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909 [TBL] [Abstract][Full Text] [Related]
20. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. Scott P; Pearce E; Natovitz P; Sher A J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]